Concerned about your own or
someone else’s drug use?

Australian methamphetamine-related clinical guidelines

The National Centre for Clinical Research on Emerging Drugs (NCCRED) commissioned the National Centre for Education and Training on Addiction (NCETA) to review Australian methamphetamine-related clinical guidelines.

Twenty-seven methamphetamine-related clinical guidelines were identified, some of which solely addressed methamphetamine (or stimulants) specifically, while others were generic but had component parts of relevance.

From this, NCETA developed a purpose-built framework to map each guideline according to treatment setting and target population. The methamphetamine-related guidelines matrix is an online representation of the framework developed by NCETA.

Click here to view the full clinical guidelines audit

Australian and International methamphetamine-related clinical guidelines and resources

The following resources were produced by the National Centre for Education and Training on Addiction (NCETA) as part of a project commissioned by NCCRED. These companion resources were formed after an audit of Australian clinical guidelines for methamphetamine use disorder as of September 2018. The full review of these can be found in the report “A Review of Australian Clinical Guidelines for Methamphetamine Use Disorder”, above.

Australian Methamphetamine Clinical Guidelines

Other Australian methamphetamine-related resources

International methamphetamine-related resources